Delivery Order SPE2DE24DA010-SPE2D626F631D
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a delivery order award valued at $8,901.70 from the Defense Logistics Agency's Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 10, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and is for performance in Santa Clara, California. The delivery order represents a task order against Abbott Vascular's larger Indefinite Delivery Contract with the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $17,250 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price contract with economic price adjustment provision will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. As a child entity of Abbott Laboratories Inc., Abbott...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $9,500 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. This delivery order represents a discrete procurement action under Abbott Vascular's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $41,268 under the Defense Logistics Agency's Medical Supply Chain program, awarded on December 5, 2025, with performance completion targeted for December 10, 2025. This fixed-price contract with economic price adjustment mechanism was awarded through full and open competition with no set-aside designation to Abbott Vascular at its Santa Clara, California location. The Defense Logistics Agency...
- Abbott Laboratories Inc. through its Abbott Vascular Inc. division received a $11,750 fixed-price delivery order (4570134220) from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025, with completion targeted for December 1, 2025. The award carries no set-aside designation and represents work to be performed in Santa Clara, California. This delivery order falls under Abbott Vascular's established cardiovascular medical technology portfolio, which includes specialized...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F631DDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in Santa Clara, California, where Abbott Vascular maintains significant operational capacity supporting the federal government's cardiovascular medical technology procurement. This delivery order represents a discrete task under Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages, devices, instrumentation, and accessories. Abbott Vascular has established itself as an essential supplier to federal healthcare systems, providing advanced cardiovascular technologies including stents, pacemakers, heart valves, implantable cardiac monitors, and left ventricular assist devices to the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare agencies. The company's federal contracting portfolio demonstrates consistent success through full and open competition mechanisms, with contract awards distributed across multiple Veterans Integrated Service Networks and federal research institutions, positioning Abbott as a strategic partner in supporting military and veteran healthcare outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 12/1/25 |